How to switch from duloxetine (Cymbalta) 20mg to citalopram (Celexa)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Switching from duloxetine (Cymbalta) 20mg to citalopram (Celexa) should be done through a cross-taper approach under medical supervision, starting with a low dose of citalopram and gradually increasing it while tapering off duloxetine. When making this switch, it's crucial to consider the potential for serotonin syndrome, especially when combining serotonergic drugs 1. The cross-taper approach helps minimize discontinuation symptoms from duloxetine, which can include dizziness, fatigue, lethargy, and anxiety 1.

Key Considerations for the Switch

  • Begin by taking duloxetine 20mg and citalopram 10mg together for 1-2 weeks to allow for gradual adjustment.
  • Then, discontinue the duloxetine while continuing citalopram 10mg for another week.
  • After this period, increase to the target dose of citalopram (typically 20mg daily) if tolerated well, monitoring for any adverse effects such as QT prolongation, which is a concern with citalopram doses exceeding 40mg/day 1.
  • It's essential to monitor for symptoms of serotonin syndrome, especially in the first 24 to 48 hours after dosage changes, as cautioned in the clinical practice guideline 1.

Monitoring and Follow-Up

  • Regular follow-up appointments are crucial to monitor the patient's response to citalopram and adjust the dose if needed.
  • Systematic assessment of treatment response using standardized symptom rating scales can be considered as a supplement to clinical judgment 1.
  • Patients should be advised to stay hydrated, maintain regular sleep patterns, and contact their doctor immediately if they experience severe symptoms like worsening mood, suicidal thoughts, or unusual behavior during the transition.

Safety and Efficacy

  • The decision to switch from duloxetine to citalopram should be based on the individual patient's needs and medical history, considering factors such as the presence of long QT syndrome or the potential for drug-drug interactions 1.
  • Medical education, training, and experience are necessary to safely and effectively prescribe antidepressant medications and manage the transition between them 1.

From the Research

Switching from Duloxetine to Citalopram

To switch from duloxetine (Cymbalta) 20mg to citalopram (Celexa), consider the following steps:

  • Gradually taper off duloxetine to minimize the risk of discontinuation syndrome, as recommended in the study 2.
  • After tapering off duloxetine, an adequate washout period may be necessary before starting citalopram, as suggested in the study 3.
  • However, some studies suggest that immediate switching from one antidepressant to another may be possible, as seen in the study 4, where patients were switched from an SSRI or venlafaxine to duloxetine without intermediate tapering or titration.
  • It is essential to monitor patients closely for potential adverse effects, including serotonin syndrome, when switching between antidepressants, as highlighted in the studies 5 and 6.

Key Considerations

  • The risk of serotonin syndrome, a potentially life-threatening condition, should be carefully monitored when switching between serotonergic agents, as reported in the studies 5 and 6.
  • Gradual dose reduction of duloxetine over days to weeks can reduce the risk and severity of complications, as suggested in the study 3.
  • Clinical expertise is necessary for more rapid or cross-taper switching, as inappropriate co-administration of antidepressants can result in drug toxicity, including serotonin syndrome, as noted in the study 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Adverse reactions to duloxetine in depression.

Expert opinion on drug safety, 2011

Research

Switching and stopping antidepressants.

Australian prescriber, 2016

Research

Immediate switching of antidepressant therapy: results from a clinical trial of duloxetine.

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.